2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)thiazolidin-4-one | 301330-12-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)thiazolidin-4-one
• 英文别名: 2-((1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)thiazolidin-4-one；(2E)-2-[1-(2-oxochromen-3-yl)ethylidenehydrazinylidene]-1,3-thiazolidin-4-one
• CAS: 301330-12-1
• 化学式: C₁₄H₁₁N₃O₃S
• 分子量: 301.326
• InChiKey: WYELPLUTRBPHLT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  105
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)thiazolidin-4-one 、 苯甲醛 在 sodium acetate 、 溶剂黄146 作用下， 反应 0.5h， 生成 5-benzylidene-2-[2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazinyl]thiazol-4(5H)-one
  参考文献：
  名称：

  一种方便的超声促进合成一些带有香豆素核的新型噻唑衍生物及其细胞毒活性。

  摘要：

  成功实施超声辐照以快速合成一系列新型 3-[1-(4-取代-5-(芳基二烯基)噻唑-2-基)肼基)乙基]-2H-chromen-2-ones 5a-h通过 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene) 氨基硫脲 (2) 和腙酰卤 3(4) 的反应，证明了这一点。此外，由反应合成了一系列新的 5-arylidene-2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazinyl)thiazol-4(5H)-ones 10a-d 2 与氯乙酸和不同的醛。此外，2-氰基-N'-(1-(2-氧代-2H-色烯-3-基)亚乙基)-乙酰肼(12)与取代的苯甲醛在所用条件下反应得到各自的亚芳基衍生物13a-c。基于元素分析和光谱数据指定合成化合物的结构。还，评估了噻唑衍生物 5a 对 HaCaT 细胞（人角质形成细胞）的细胞毒活性。发现化合物5a具有有效的细胞毒活性。

  DOI：

  10.3390/molecules17089335
• 作为产物：
  描述：

  3-乙酰基香豆素 在 盐酸 、 sodium acetate 、 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 0.5h， 生成 2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazono)thiazolidin-4-one
  参考文献：
  名称：

  一种方便的超声促进合成一些带有香豆素核的新型噻唑衍生物及其细胞毒活性。

  摘要：

  成功实施超声辐照以快速合成一系列新型 3-[1-(4-取代-5-(芳基二烯基)噻唑-2-基)肼基)乙基]-2H-chromen-2-ones 5a-h通过 2-(1-(2-oxo-2H-chromen-3-yl)ethylidene) 氨基硫脲 (2) 和腙酰卤 3(4) 的反应，证明了这一点。此外，由反应合成了一系列新的 5-arylidene-2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazinyl)thiazol-4(5H)-ones 10a-d 2 与氯乙酸和不同的醛。此外，2-氰基-N'-(1-(2-氧代-2H-色烯-3-基)亚乙基)-乙酰肼(12)与取代的苯甲醛在所用条件下反应得到各自的亚芳基衍生物13a-c。基于元素分析和光谱数据指定合成化合物的结构。还，评估了噻唑衍生物 5a 对 HaCaT 细胞（人角质形成细胞）的细胞毒活性。发现化合物5a具有有效的细胞毒活性。

  DOI：

  10.3390/molecules17089335

文献信息

• Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity
  作者：Simone Carradori、Bruna Bizzarri、Melissa D'Ascenzio、Celeste De Monte、Rossella Grande、Daniela Rivanera、Alessanda Zicari、Emanuela Mari、Manuela Sabatino、Alexandros Patsilinakos、Rino Ragno、Daniela Secci

  DOI：10.1016/j.ejmech.2017.09.026

  日期：2017.11

  hundred compounds characterized by a 1,3-thiazolidin-4-one nucleus derivatised at the C2 with a hydrazine bridge linked to (cyclo)aliphatic or hetero(aryl) moieties, and their N-benzylated derivatives. These molecules were assayed as potential anti-Candida agents and they were shown to possess comparable, and in some cases higher biological activity than well-established topical and systemic antimycotic drugs

  参考有关噻唑烷酮支架各种生物学特性的最新研究报告，我们合成了一百多种化合物，这些化合物的特征是1,2噻唑烷酮-4-酮核在C2处衍生化，并带有与（环）脂族连接的肼桥。或杂（芳基）部分，以及它们的N-苄基衍生物。这些分子被作为潜在的抗念珠菌药物进行了分析，显示它们具有与成熟的局部和全身性抗真菌药物（即克霉唑，氟康唑，酮康唑，咪康唑，噻康唑，两性霉素B）相当的生物活性，在某些情况下具有更高的生物学活性。具有最低MIC的化合物进行了进一步测试，以评估其细胞毒性作用（CC 50）在Hep2细胞上，证明了其相对安全性。最后，使用QSAR和3-D QSAR模型预测1,3-噻唑烷丁-4-酮支架的假定化学修饰，以设计针对念珠菌的新的和潜在的更具活性的化合物。
• Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii
  作者：Melissa D'Ascenzio、Bruna Bizzarri、Celeste De Monte、Simone Carradori、Adriana Bolasco、Daniela Secci、Daniela Rivanera、Nathan Faulhaber、Claudia Bordón、Lorraine Jones-Brando

  DOI：10.1016/j.ejmech.2014.08.046

  日期：2014.10

  We designed and synthesized a large number of novel thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii activity. This scaffold was functionalized at the N1-hydrazine portion with aliphatic, cycloaliphatic and (hetero)aromatic moieties. Then, a benzyl pendant was introduced at the lactamic NH of the core nucleus to evaluate the influence of this chemical modification on biological activity. The compounds were subjected to several in vitro assays to assess their anti-parasitic efficacy, cytotoxicity on fibroblasts, inhibition of tachyzoite invasion/attachment and replication after treatment. Results showed that fourteen of these thiazole-based compounds compare favorably to control compound trimethoprim in terms of parasite growth inhibition. (c) 2014 Elsevier Masson SAS. All rights reserved.
• New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies
  作者：Somaia S. Abd El-Karim、Yasmin M. Syam、Ahmed M. El Kerdawy、Tamer M. Abdelghany

  DOI：10.1016/j.bioorg.2019.01.026

  日期：2019.5

  Motivated by the potential anticancer activity of both coumarin and 2-aminothiazole nuclei, a new set of thiazol-2-yl hydrazono-chromen-2-one analogs were efficiently synthesized aiming to obtain novel hybrids with potential cytotoxic activity. MTT assay investigated the significant potency of all the target compounds against the human cervical cancer cell lines (HeLa cells). Cell cycle analysis showed that the representative compound 8a led to cell cycle cessation at G0/G1 phase indicating that CDK2/E1complex could be the plausible biological target for these newly synthesized compounds. Thus, the most active compounds (7c and 8a-c) were tested for their CDK2 inhibitory activity. The biological results revealed their significant CDK2 inhibitory activity with IC50 range of 0.022-1.629 nM. Moreover, RT-PCR gene expression assay showed that compound 8a increased the levels of the nuclear CDK2 regulators P21 and P27 by 2.30 and 5.7 folds, respectively. ELISA tequnique showed also that compound 8a led to remarkable activation of caspases-9 and -3 inducing cell apoptosis. QSAR study showed that the charge distribution and molecular hydrophobicity are the structural features affecting cytotoxic activity in this series. Molecular docking study for the most potent cytotoxic compounds (7c and 8a-c) rationalized their superior CDK2 inhibitory activity through their hydrogen bonding and hydrophobic interactions with the key amino acids in the CDK2 binding site. Pharmacokinetic properties prediction of the most potent compounds showed that the newly synthesized compounds are not only with promising antitumor activity but also possess promising pharmacokinetic properties.